HM6-13272-01371
3 vaccinations
11 coded responses
28 check-ins
4 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 917 / CA
- Registered
- 2021-03-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-30
Registered in v-safe
-
2021-03-30
Dose 1 — Pfizer-BioNTech
-
2021-04-02
Survey response — days 1–6 daily, dose 1MedDRA: Rhinorrhoea — Feeling: Poor · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-04
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Joint pains, NauseaAdult check-in
-
2021-04-05
Survey response — days 1–6 daily, dose 1MedDRA: Rhinorrhoea — Feeling: Fair · Fatigue or tirednessFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-06
Survey response — day 7, dose 1MedDRA: Rhinorrhoea — Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-15
-
2021-04-20
Dose 2 — Pfizer-BioNTech
-
2021-04-20
Health check-in — day 0, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-04-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-22
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-04-23
Health check-in — days 1–6 daily, dose 2Feeling: Good · Chills, Headache, Fatigue or tirednessAdult check-in
-
2021-04-25
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness, Syncope — Feeling: Good · Fatigue or tiredness, NauseaFree text: Mareo y syncopeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-26
- 2021-04-27
- 2021-05-06
- 2021-05-11
- 2021-05-18
- 2021-05-25
-
2021-06-01
Survey response — day 42, dose 2MedDRA: Abdominal pain upper, Chills, Diarrhoea, Headache, Nausea — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11
-
2021-07-22
Survey response — 3 months, dose 2MedDRA: Diarrhoea, Nausea, Pain — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
-
2021-10-20
Dose 3 — Pfizer-BioNTech
-
2021-10-25
Survey response — days 1–6 daily, dose 3MedDRA: Oropharyngeal pain — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitMedDRA releases: 2024-11
-
2021-10-25
Report sent to call center — days 1–6 daily, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
- 2021-10-26
-
2021-10-27
Survey response — day 7, dose 3MedDRA: Chest pain, Cough, Oropharyngeal pain — Feeling: Fair · Site: Pain, Itching · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
-
2021-11-03
Survey response — day 14, dose 3MedDRA: Abdominal pain upper, Diabetes mellitus inadequate control, Fatigue, Vomiting — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitMedDRA releases: 2024-11
-
2021-11-03
Report sent to call center — day 14, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2021-11-08
- 2021-11-11
- 2021-11-12
- 2021-11-17
- 2021-11-24
- 2021-12-04
-
2022-01-19
Survey response — 3 months, dose 3MedDRA: Adverse reaction — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitMedDRA releases: 2024-11
-
2022-01-19
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
- 2022-01-22
- 2022-01-27
-
2022-01-27
Callback requested for07:00PM ET
-
2022-01-27
Call successfulCompleted over the phone
-
2022-04-20
Survey response — 6 months, dose 3MedDRA: Cough, Pain — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2022-10-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Pfizer-BioNTech | |
| 2 | 2021-04-20 | Pfizer-BioNTech | |
| 3 | 2021-10-20 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 successful
VAERS report filed, before or during a call: 3
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Runny nose
Systemic reaction (other): Runny nose
Release 7 — day 7, dose 1
Systemic reaction (other): Runny nose
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Mareo y syncope
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain upper | ✓ | ✓ | ✓ |
| SD | Adverse reaction | · | · | ✓ |
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Diabetes mellitus inadequate control | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Chest pain | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Syncope | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release